Form 8-K - Current report:
SEC Accession No. 0001615219-25-000107
Filing Date
2025-08-18
Accepted
2025-08-18 08:33:54
Documents
12
Period of Report
2025-08-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K flks-20250817.htm   iXBRL 8-K 29324
  Complete submission text file 0001615219-25-000107.txt   147390

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20250817.xsd EX-101.SCH 1807
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20250817_lab.xml EX-101.LAB 22592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20250817_pre.xml EX-101.PRE 13078
15 EXTRACTED XBRL INSTANCE DOCUMENT flks-20250817_htm.xml XML 3141
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 251226352
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)